The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

CORONARY INTERVENTIONS

Everolimus-eluting stent for the treatment of bare metal in-stent restenosis: clinical and angiographic outcomes at nine-month follow-up of XERES (Xience Evaluation in bare metal stent REStenosis) trial

EuroIntervention 2014;10:700-708 published online ahead of print December 2013. DOI: 10.4244/EIJV10I6A122

1. Cardiology B, Cardiovascular and Metabolic Pole, Rangueil Hospital, Toulouse, France; 2. Cardiology Department, Hospital Centre, Pau, France; 3. Cardiology Department, Arnaud de Villeneuve Hospital, Montpellier, France; 4. Cardiology Department, St. Hi

Aims: Restenosis is a frequent complication of coronary stent implantation, especially bare metal stent (BMS) implantation. The everolimus-eluting stent (EES) has previously been shown to

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Coronary stents seeded with human trophoblastic endovascular progenitor cells show accelerated strut coverage without excessive neointimal proliferation in a porcine model